(Q34466439)

2 August 2017

1 reference

title

Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension (English)

1 reference

microvasculature remodeling

2 August 2017

main subject

arterial hypertension

0 references

1 reference

Jeffery TK

1

1 reference

2 August 2017

Wanstall JC

series ordinal

2

1 reference

2 August 2017

publication date

1 October 2001

1 reference

Pharmacology & Therapeutics

2 August 2017

published in

1 reference

2 August 2017

volume

92

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

1-20

1 reference

Hypoxia-induced release of peptide growth factors from neonatal porcine pulmonary artery smooth muscle cells.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Role of nitric oxide in regulating neonatal porcine pulmonary artery smooth muscle cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Hypoxic pulmonary vasoconstriction in chronically hypoxic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Transforming growth factor-beta 1 is decreased in remodeling hypertensive bovine pulmonary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Primary pulmonary hypertension and fenfluramine use

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin-1 in Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Identification of stretch-responsive genes in pulmonary artery smooth muscle cells by a two arbitrary primer-based mRNA differential display approach

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effects of Cilazapril, a Novel Angiotensin Converting Enzyme Inhibitor, on the Structure of Pulmonary Arteries of Rats Exposed to Chronic Hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Characterization of fibroblast mitogens and chemoattractants produced by endothelial cells exposed to hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Insulin-like growth factor I and protein kinase C activation stimulate pulmonary artery smooth muscle cell proliferation through separate but synergistic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Colliquation therapy of myoadenomatous prostatic hyperplasia (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Mechanical Properties and Reactivity of Vessels in Isolated Perfused Lungs of Chronically Hypoxic Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelial cell responses to hypoxic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Neither anticoagulant nor nonanticoagulant heparin affects monocrotaline lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Quantitative changes in the rat pulmonary vasculature in chronic hypoxia--relation to haemodynamic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The Haemodynamic Consequences of Adaptive Structural Changes of the Resistance Vessels in Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Nitric oxide and endothelin-1 in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Polyamines and epidermal growth factor in monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The pulmonary hypertensive fawn-hooded rat has a normal serotonin transporter coding sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Increased plasma serotonin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The effect of nifedipine on monocrotaline-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Nitric oxide impacts endothelin-1 gene expression in intrapulmonary arteries of chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Failure to show decrease in small pulmonary blood vessels in rats with experimental pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pulmonary artery pressure in rats with hereditary platelet function defect

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Reduction of chronic hypoxic pulmonary hypertension in the rat by beta-aminopropionitrile

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Both membrane stretch and fatty acids directly activate large conductance Ca2+ -activated K+ channels in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Stretch increases inositol trisphosphate and inositol tetrakisphosphate in cultured pulmonary vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin induced collagen remodeling in experimental pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Impaired endothelial function in epicardial coronary arteries after Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Development of monocrotaline-induced pulmonary hypertension is attenuated by a serotonin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Monocrotaline-induced pulmonary fibrosis in rats: amelioration by captopril and penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Insulin-like Growth Factor I and Pulmonary Hypertension Induced by Continuous Air Embolization in Sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Collagen and elastin metabolism in hypertensive pulmonary arteries of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Platelet-derived growth factor and angiotensin II cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pulmonary Hypertensive Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Angiotensin converting enzyme expression in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Cellular and molecular mechanisms of pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Amlodipine and vascular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effects of SCH 34826, a neutral endopeptidase inhibitor, on hypoxic pulmonary vascular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The effect of nitric oxide on fetal pulmonary artery smooth muscle growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pathogenesis of pulmonary hypertension in the rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Chronic hypoxia-induced cardiopulmonary changes in three rat strains: inhibition by the endothelin receptor antagonist SB 217242

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Role of endothelial cells in the proliferative response of cultured pulmonary vascular smooth muscle cells to reduced oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effect of alveolar pressure on pulmonary artery pressure in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Effects of tetrandrine on growth factor-induced DNA synthesis and proliferative response of rat pulmonary artery smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Recognition and management of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Prostacyclin Analogues Differentially Inhibit Growth of Distal and Proximal Human Pulmonary Artery Smooth Muscle Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Neutral Endopeptidase 24.11 Inhibition Reduces Pulmonary Vascular Remodeling in Rats Exposed to Chronic Hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Endothelin-1 activates MAP kinases and c-Jun in pulmonary artery smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

Alteration of the pulsatile load in the high-altitude calf model of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2801%2900157-7

7 January 2021

10.1016/S0163-7258(01)00157-7

Identifiers

DOI

1 reference

2 August 2017

1 reference